491 results on '"Conrad, Charles A."'
Search Results
2. Direct Writing Prediction Models Identify At-Risk Writers
3. Whistleblowing, Identity Construction, and Strategic Communication
4. CLOWN BANDS.
5. TRIBUTE TO CHESTER Z. BRONSON (1857-1923).
6. Supplementary Video from Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors
7. Supplementary Table from Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors
8. Data from Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors
9. Supplementary Figure 3 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
10. Supplementary Figure 4 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
11. Supplementary Figure 1 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
12. Supplementary Figure 6 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
13. Supplemental Table 1 from Genetic Modulation of Neurocognitive Function in Glioma Patients
14. Supplementary Figure 5 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
15. Supplementary Figure 2 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
16. Supplementary Figure Legends from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
17. Data from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
18. Supplementary Figure 1 from A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients
19. Data from A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients
20. Reply on RC2
21. The Role of Inflammation in Brain Cancer
22. Organizational Communication and Organizational Rhetoric I
23. Aristotle, Burke, and Beyond
24. GC Insights: Communicating Climate Change – Immersive Sonification for the Piano
25. Supplementary material to "GC Insights: Communicating Climate Change – Immersive Sonification for the Piano"
26. Therapeutic targets in subependymoma
27. Innovative Treatment Strategies for High-Grade Gliomas
28. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
29. William N. Merrick (1856-1938), Inductee 2005.
30. Rhetoric and the Origins of the Canadian Medicare System
31. Systemic Chemotherapy for Metastatic Tumors of the Central Nervous System
32. Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection
33. d-Glucose and d-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated d-glucose, d-mannose, and 2-deoxy-d-glucose
34. The Illusion of Reform: Corporate Discourse and Agenda Denial in the 2002 "Corporate Meltdown"
35. Wound healing complications in brain tumor patients on Bevacizumab
36. Leadership Self-Perceptions of WLC Participants.
37. Rhetoric and the Origins of the Canadian Medicare System
38. WILLIAM F. WELDON (1860-1923), Inductee 2012.
39. High mass accuracy and resolution facilitate identification of glycosphingolipids and phospholipids
40. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
41. GC Insights: Communicating Climate Change – Immersive Sonification for the Piano.
42. Contributors
43. Brain Metastasis from Solid Tumors
44. The Illusion of Reform: Corporate Discourse and Agenda Denial in the 2002 "Corporate Meltdown"
45. Political Debates as Televisual Form.
46. Identity, Structure and Communicative Action in Church Decision-Making
47. A Marl Marsh Natural Area in Eastern West Virginia
48. Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients
49. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
50. Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.